SYnabs, Unisensor, Coris BioConcept and Bio-X Diagnostics, have together developed a COVID individual rapid test that is a world premiere -- MEDICA - World Forum for Medicine

08/10/2020

SYnAbs S.A.

SYnabs, Unisensor, Coris BioConcept and Bio-X Diagnostics, have together developed a COVID individual rapid test that is a world premiere

Unlike the products marketed to date, the test developed by SYnabs, Coris BioConcept, Unisensor, and Bio- X Diagnostics, is the only rapid solution (developed in different formats) that can detect an immune response against two specific Coronavirus / Covid-19 "markers". This 100% Walloon innovation makes it possible to detect not only a greater number of people who have been contaminated but also to identify those who have developed a neutralizing, potentially protective immune response.

Exhibitor Data Sheet